Summary:
Men and women at least 16 years old are needed to participate in a clinical research study testing the effects of two marketed drugs in patients with epilepsy. Participants must be on a stable anti-epileptic drug regimen that includes carbamazepine or phenytoin.
Qualified Participants Must:
• be at least 16 years of age
• have epilepsy
• currently be taking carbamazepine or phenytoin
Qualified Participants May Receive:
Compensation offered for time and travel.